(Q28290005)

English

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity

scientific article

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab

In more languages

Statements

scholarly article

0 references

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity (English)

0 references

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab (English)

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hans-Peter Hartung

4

0 references

5

0 references

Gerd Meyer zu Hörste

3

object named as

G. Meyer zu Hörste

1 reference

DOI.org query endpoint

9 April 2017

author name string

Verena I Leussink

1

0 references

Helmar C Lehmann

2

0 references

Gerd Meyer zu Hörste

3

0 references

Bernd C Kieseier

6

0 references

V. I. Leussink

1

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

H. C. Lehmann

2

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

H.-P. Hartung

4

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

O. Stüve

5

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

B. C. Kieseier

6

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

language of work or name

0 references

publication date

September 2008

0 references

17 July 2008

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

Journal of Neurology

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

255

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

9

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

1436-8

0 references

1436-1438

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab effects on immune cell responses in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The B cell--old player, new position on the team

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis: a complicated picture of autoimmunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment and treatment trials in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunopathology of multiple sclerosis: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/18685916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-008-0956-X

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00415-008-0956-X

9 April 2017

Dimensions Publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28290005&oldid=2177597285"